Outpatient medication-assisted treatment for hydrocodone, Vicodin, Norco, and Lortab dependence — for patients who started with a prescription and never expected to end up here. Four clinics across Southeast Tennessee and North Georgia, same-day appointments available.
CARF AccreditedLicensed in Tennessee & GeorgiaSame-day appointments availableConfidential from your first call
At a glance
How we treat hydrocodone addiction
Read summaryHide+
Restoration Recovery treats hydrocodone addiction — including Vicodin, Norco, and Lortab (hydrocodone+acetaminophen) — with FDA-approved buprenorphine MAT at four outpatient clinics across Tennessee and Georgia. Daily Suboxone film or tablet is the most common starting medication for prescription-pill patients; long-acting injectables (Sublocade, Brixadi) become appropriate when daily adherence is difficult or when tolerance has climbed. Sordo 2017 BMJ documents buprenorphine cutting overdose mortality roughly in half.
First visits include DSM-5 evaluation, COWS scoring, counseling intake, doctor evaluation, and medication ordering. Same-week appointments; TennCare, BlueCare, BCBS, UHC, and most commercial insurance accepted.
What Is Hydrocodone?
Hydrocodone is a semi-synthetic opioid used to treat moderate-to-moderately-severe pain. Chemically, it sits between codeine and oxycodone in potency. Clinically, it has been one of the most widely prescribed medications in the United States for the better part of three decades — not just the most prescribed opioid, but at its peak one of the most prescribed medications of any kind. If you took a pain pill after dental work, after a back injury, after a C-section, after a broken ankle — there is a very good chance it was hydrocodone.
The drug is almost always sold in a combination formulation. Pure hydrocodone products exist (Zohydro ER, Hysingla ER) but are uncommon. The pills most patients encounter are combination products: Vicodin, Lortab, Norco, and Lorcet (hydrocodone + acetaminophen, the active ingredient in Tylenol), Vicoprofen and Reprexain (hydrocodone + ibuprofen), and Hycodan (hydrocodone + homatropine, used as a cough suppressant). The acetaminophen and ibuprofen aren’t incidental — they’re a clinical feature that, at high chronic doses, becomes a second medical problem on top of the opioid dependence itself.
Until October 2014, all of these combination products sat in Schedule III of the Controlled Substances Act. That meant they could be refilled by phone, faxed, called in by a provider, and were generally treated as lower-risk than pure opioids like oxycodone or morphine. In response to clear evidence of widespread abuse and dependence, the DEA moved hydrocodone combination products from Schedule III to Schedule II effective October 6, 2014. Overnight, the same pills required a written or electronic prescription with no phone-in refills, a new prescription every fill, and in most states tighter monitoring. A 2019 study found that 78.8% of physicians reported modifying their prescribing behavior after the rescheduling.
That change, combined with the 2012 launch of Tennessee’s mandatory Controlled Substance Monitoring Database (CSMD), cut hydrocodone prescribing sharply. But for patients who had already built physical dependence during the decade of liberal prescribing, the tap didn’t just turn off — it created a sudden access problem. What happened next, on a population scale, is the story of the American opioid crisis. And it’s the story a lot of our hydrocodone patients lived through personally.
TN opioid prescribing, peak → decline
Opioid prescriptions per person, Tennessee
1.42012 peak
0.972017
0.352024 (US avg)↓ 75% since peak
Tennessee peaked at 1.4 opioid prescriptions per resident in 2012 (2nd-highest in the U.S.). By 2017, total Rx volume was down 20% from peak; MMEs down 32%. The national rate reached 35.4 Rx per 100 persons in 2024.
Counterfeit pills seized nationally
Fentanyl-laced fake M30 and combo pills
2 mgLethal dose
6 in 10Contain lethal dose
115MSeized 2023fentanyl-laced pills
Roughly 115 million counterfeit pills were seized in U.S. High Intensity Drug Trafficking Areas in 2023 — about half of all fentanyl seizures. Approximately 6 in 10 contained a potentially lethal dose of fentanyl (≥2 mg). These pills are pressed to look like legitimate hydrocodone, oxycodone, Xanax, or Adderall.
From the Prescription Pad to the Pill Bottle
Most of our hydrocodone patients don’t fit the picture most people have of “addiction.” They were prescribed Vicodin after surgery. They were given Lortab for back pain after an injury at work. They were sent home with a bottle of Norco after a car accident, with instructions to take one every six hours as needed.
And for a while, the pills did exactly what they were supposed to do. Then the prescription ran out. Or the prescription didn’t run out, but the pain outran the dose, and two pills weren’t enough anymore. Or the prescription ran out and the pain came back. Or the prescription ran out and the pain was mostly gone but the feeling of the pill — calm, slightly euphoric, a buffer between you and the day — was something worth keeping. Any one of those paths can end at the same place.
The numbers tell part of it. Tennessee’s opioid prescribing rate peaked in 2012 at roughly 1.4 prescriptions per person — the second-highest in the country. That was one opioid prescription for every man, woman, and child in the state, with 40% to spare. Nationwide, the rate has now fallen to 35.4 prescriptions per 100 persons (2024) from 46.8 per 100 in 2019. The decline is real. It has also left a generation of patients with physical dependence and no prescription, looking for another way to stop the withdrawal.
The second chart is what that second way looks like now. Starting around 2016, the illicit pill supply in the United States underwent a quiet replacement: the “oxycodone 30” (M30) tablets that used to circulate as diverted pharmaceuticals became counterfeit pressings made overseas. The pills look identical to the real thing. They contain no oxycodone and no hydrocodone. They contain fentanyl. In 2022, six in ten seized counterfeit pills contained a potentially lethal dose (at least 2 milligrams). In 2023, U.S. law enforcement seized about 115 million of them — roughly half of all fentanyl seizures nationally.
This matters for every patient on this page. If you ran out of your prescription and bought pills that looked like hydrocodone, Percocet, or “30s” from anyone outside a pharmacy, you were almost certainly exposed to fentanyl. That doesn’t change what MAT looks like for you, but it changes how urgent it is. The difference between your prescribed dose and an unknown fentanyl dose is the difference between survivable and not. The same treatment that would have worked five years ago works now — it just needs to start sooner.
Sources: Federal Register, Rescheduling of Hydrocodone Combination Products (DEA, August 2014); Sycamore Institute, Tennessee Opioid Epidemic: 2018 Indicators (2012 peak data); CDC, U.S. Opioid Dispensing Rate Maps (2024 national rate); NIH press release, Over 115 million pills containing illicit fentanyl seized by law enforcement in 2023; CDC, Rx Awareness / Counterfeit Pills; JAMA Network Open, State-to-State Variation in Opioid Dispensing (2023).
Recognizing it
Signs of Hydrocodone Use Disorder
Hydrocodone use disorder is a medical condition, not a character flaw. It also isn’t always loud. The prescription-opioid version of opioid dependence often looks like a person holding a normal-looking life together while the pills quietly run the math in the background. Common signs include:
Tolerance and dose escalation. The pills that worked when they were first prescribed don’t anymore — or the prescribed amount wears off sooner than it used to. Doses creep up. Two becomes three becomes four. The total daily amount is often well above what was originally prescribed.
Running out early. The 30-day prescription lasts 22 days. Then 18. Then 14. A pattern of frequent “lost” prescriptions, “stolen” bottles, or early refill requests is one of the clearest signals clinicians see.
Doctor-shopping or multi-sourcing. Visiting more than one provider to keep supply steady — urgent-care clinics, ER visits, a dentist, a pain clinic, a family doctor — often without each one knowing about the others. Since Tennessee’s CSMD database requires providers to check prescription history before writing Schedule II opioids, this pattern is now far easier to detect than it used to be, which often pushes patients toward the next sign.
Switching to cheaper or stronger alternatives. When the prescription access closes or becomes too expensive, patients commonly switch to illicit pills (“30s,” “Roxies,” off-the-street Lortab), to heroin, or — increasingly and unknowingly — to fentanyl. The same person who never dreamed they’d buy drugs on the street can end up doing exactly that, because the alternative is withdrawal.
Withdrawal fear driving use. Taking pills not for pain, not for any real feeling — just to not be sick. The morning dose before work. The extra dose before a family event because you know what 8 hours without one feels like. Life starts getting scheduled around dose timing.
Loss of control. Deciding you’ll only take two today and taking four. Deciding you’ll skip today and not being able to. Making and breaking the same “last pill” promise to yourself or a spouse for months or years.
Hiding use. Taking pills somewhere no one will see. Lying about how many are left. Emptying part of a bottle into a different container. This is often the first sign a family member notices — the behavior around the pills, not the pills themselves.
Liver or GI symptoms from the combination ingredient. High chronic doses of Vicodin, Lortab, or Norco also deliver high chronic doses of acetaminophen. Persistent fatigue, right-upper-quadrant abdominal pain, nausea, or jaundice can reflect acetaminophen-related liver strain and should be worked up. This is a medical concern distinct from the opioid dependence itself.
Continued use despite consequences. Using even when it’s costing you — financially, at work, in relationships, in health, in court. Continued use in the face of mounting consequences is one of the DSM-5 criteria for opioid use disorder.
You do not have to meet every item on this list. The formal DSM-5 threshold for opioid use disorder is 2 of 11 criteria in a 12-month period. Mild, moderate, and severe are all treatable — and treatment earlier is almost always easier than treatment later.
Hydrocodone Withdrawal: Timeline & Symptoms
Hydrocodone withdrawal is uncomfortable. For most healthy adults it is not life-threatening the way alcohol or benzodiazepine withdrawal can be, but it can be severe enough that many patients relapse simply to stop the symptoms. That’s the physiology of dependence, not a willpower problem — and medication-assisted treatment prevents the withdrawal instead of making you push through it. Hydrocodone is considered a short-to-medium-acting opioid — its half-life is roughly 3.8 hours, which means withdrawal onset is faster and more predictable than with longer-acting opioids or with lipid-stored opioids like fentanyl.
First 6–12 hours after last dose
Early symptoms
Anxiety, restlessness, irritability, muscle aches, yawning, watery eyes, runny nose, sweating, and craving. Sleep often becomes difficult the first night. This phase typically hits faster than fentanyl withdrawal (which can take 8–24+ hours to begin).
Day 1 – Day 3 · Peak
The peak
Full symptom picture: nausea, vomiting, diarrhea, abdominal cramping, chills alternating with sweating, dilated pupils, goosebumps (“kicking”), muscle and bone aches, profound fatigue, and intense cravings. Heart rate and blood pressure rise. Insomnia persists. This is the window when most unmedicated attempts to stop fail.
This is the stretch MAT is built for — buprenorphine prevents these symptoms, so most patients never go through the peak unmedicated.
Acute GI symptoms gradually subside. Appetite may start to return. Sleep is still fragmented. Cravings remain strong. Low mood and anxiety often peak here as the body re-regulates.
Week 2 and beyond · Post-acute
Post-acute withdrawal
Low energy, difficulty concentrating, mood changes, anhedonia, and intermittent cravings can last weeks to several months. This doesn’t mean treatment is failing. The nervous system is slowly re-calibrating after years of opioid exposure, and MAT dramatically shortens and softens this phase.
Two considerations specific to hydrocodone
Combination-product considerations: if you’ve been taking high-dose Vicodin, Lortab, or Norco chronically, you’ve also been taking high-dose acetaminophen. Our intake providers routinely review liver function and can coordinate a liver panel when clinically appropriate — and starting MAT stops the ongoing acetaminophen exposure, which is itself a medical benefit. Induction timing: starting buprenorphine too early after your last hydrocodone dose can trigger precipitated withdrawal. The target window is typically a moderate COWS score, usually 6–24 hours after last use; for patients also exposed to fentanyl via counterfeit pills, the window is often longer (36–72 hours) because fentanyl clears more slowly. Your provider measures COWS at intake to time induction correctly.
How We Treat Hydrocodone Addiction
Every opioid patient is evaluated for medication-assisted treatment, because the evidence is overwhelming: more than a 50% reduction in fatal overdose risk, significantly longer retention in treatment, and sharply lower rates of illicit opioid use. We pair MAT with psychosocial support and integrated care for co-occurring conditions — for prescription-opioid patients, chronic pain and anxiety are particularly common and directly relevant to how long people stay in treatment.
Buprenorphine + naloxone taken sublingually as a dissolving film or tablet under the tongue. Buprenorphine is a partial opioid agonist: it stabilizes cravings and prevents withdrawal at the same receptors hydrocodone was acting on, but with a ceiling on euphoria and respiratory depression. For many Rx-opioid-first patients, same-day Suboxone induction is clinically appropriate and dramatically easier than a cold-turkey attempt. The naloxone component is inactive when the medication is taken correctly; it’s included to discourage misuse via injection.
A long-acting extended-release form of buprenorphine administered once per month at our clinics. Many patients who start on Suboxone transition to Sublocade because it removes the daily decision-making around taking medication, holds steadier blood levels through the month, and — importantly for patients whose dependence began with pill-taking — removes the pill ritual entirely. Per FDA labeling, Sublocade requires at least 7 days of transmucosal buprenorphine (Suboxone) before the first injection.
Brixadi (weekly or monthly)
Another extended-release buprenorphine injection, with flexible dosing intervals. Brixadi’s weekly option can help patients still finding the right maintenance dose, or who want more frequent clinic contact than Sublocade’s monthly cadence. Like Sublocade, Brixadi is ordered per-patient and administered at a follow-up visit once the medication arrives.
Individual counseling
Licensed therapists experienced in substance use disorder. Counseling for prescription-opioid patients often surfaces material specific to this pathway — the original pain event, the relationship with the original prescribing provider, the shame of needing pills to function, and the impact on the family of years of hidden use.
Certified peer support
Specialists with lived recovery experience of their own. Many of our peers have walked the same Rx-to-street-to-recovery arc our patients are walking, and that conversation can unlock what a clinical conversation sometimes can’t.
For patients who benefit from a more structured treatment schedule — delivered in a group format by design. IOP is the only group-setting service we offer, and it’s a separate, structured program rather than an informal group activity.
Integrated behavioral health
Integrated care for co-occurring conditions, including anxiety, depression, trauma, chronic pain, and hepatitis C. For Rx-opioid patients, chronic pain and anxiety are particularly common and directly relevant to retention — we address them rather than hand them off.
Chronic Pain Considerations
A large share of our hydrocodone patients arrive with a legitimate chronic pain history, and many of them have been told somewhere along the way that starting MAT means giving up pain management. That’s not how the clinical picture actually works. Buprenorphine — the active medication in Suboxone, Sublocade, and Brixadi — is itself a potent analgesic. As a partial opioid agonist, it provides real, measurable pain relief, and plenty of our patients report their pain is better controlled on buprenorphine than it was on escalating hydrocodone, largely because their nervous system stops cycling through mini-withdrawal between doses.
When a patient has an active pain management relationship with another provider, we coordinate rather than compete. The goal is one consistent plan between us, the pain provider, and the patient — not two parallel medication lists that contradict each other. If you’ve been told you have to choose between recovery and pain management, that isn’t the clinical reality. It’s a conversation worth having at intake.
Most patients with hydrocodone use disorder start MAT right in our outpatient clinics — buprenorphine can begin at the appropriate COWS-score window after last use, under clinical supervision. Some situations do need medical stabilization first: a severe untreated co-occurring psychiatric illness, or a serious medical complication, is an emergency that needs hospital-level care before outpatient treatment. Get those evaluated urgently, and we’ll get you started on MAT as soon as you’re medically cleared.
Not sure where to start?
You don’t have to be in withdrawal, and you don’t have to have stopped. Call and we’ll walk you through the first visit and time your medication correctly.
Your first visit typically lasts 2 to 3 hours and follows a four-step clinical flow. The COWS score is what times your first dose — you leave the same day with a Suboxone prescription.
01
Intake
Paperwork, a DSM-5 assessment to confirm diagnosis and severity, and a COWS score to measure your current withdrawal state — the score guides whether you can start buprenorphine the same day or need a longer interval.
02
Counseling
You meet a counselor to discuss your use history — including the original prescription pathway if that’s how it started — prior treatment, co-occurring conditions, and recovery goals. Any active pain management relationship or concern gets documented here.
03
Doctor evaluation
A provider reviews your intake, COWS score, and counselor notes, walks you through Suboxone, Sublocade, and Brixadi, and — for long Vicodin/Lortab/Norco histories — addresses any liver function or acetaminophen-related concern.
04
Prescription
You leave the same day with a Suboxone prescription. If you prefer the extended-release route, your provider orders Sublocade or Brixadi during this visit and you bridge on Suboxone until your injection appointment.
About 2–3 hours.You leave the same day with a Suboxone prescription.Bring a photo ID, insurance card, and a list of any medications.
What each step covers in detail+
Intake. A DSM-5 assessment to confirm opioid use disorder and its severity (mild, moderate, or severe, based on the 11 criteria met in a 12-month period), plus a COWS (Clinical Opiate Withdrawal Scale) score to measure your current withdrawal state. The COWS score guides whether you’re clinically ready to begin buprenorphine the same day without risking precipitated withdrawal.
Counseling. You’ll meet with a counselor to discuss your substance use history — including the original prescription pathway if that’s how your use started — any previous treatment, any co-occurring mental health conditions, and your personal recovery goals. This is also where any active pain management relationship or concern gets documented.
Doctor evaluation. A medical provider reviews your intake, COWS score, and counselor notes. They walk you through the medication options (Suboxone, Sublocade, Brixadi), explain onset, side effects, and timing, and answer your questions. For patients with long Vicodin/Lortab/Norco histories, this is also where any liver function or acetaminophen-related concern is addressed.
Prescription and injection ordering. You leave the same day with a Suboxone prescription. If you prefer the extended-release route, your provider orders Sublocade or Brixadi during this visit — we don’t stock injections on-site — and you continue on Suboxone as a bridge. Your injection appointment is scheduled for a follow-up once the medication arrives, typically after a short stabilization period on Suboxone (Sublocade’s FDA label requires at least 7 days of transmucosal buprenorphine before the first injection).
What to bring. A valid photo ID, your insurance card if applicable, and a list of any medications you currently take (including the hydrocodone product and dose, the original prescribing reason, and any pain medications or benzodiazepines). Our guide on what to expect at your first Suboxone appointment covers the process in more detail.
Why Medication-Assisted Treatment Works for Hydrocodone
For many patients, the fear of withdrawal is what keeps them stuck. MAT removes that barrier: the medication prevents withdrawal, so the fear that keeps people stuck stops being the obstacle. MAT is endorsed as the standard of care for opioid use disorder, including prescription opioid use disorder specifically, by SAMHSA, NIDA, ASAM, and the World Health Organization. Prescription opioid use disorder was actually the population in which buprenorphine was most extensively studied prior to the illicit-fentanyl era — the original large trials (COMBINE, POATS, and others) recruited patients whose dependence began with pills, not injection use. Large-scale evidence shows that patients on buprenorphine-based MAT:
Experience more than a 50 percent reduction in the risk of fatal opioid overdose
Stay in treatment significantly longer than those receiving counseling alone
Report fewer cravings and lower rates of illicit opioid use
Are more likely to maintain employment and stable housing during recovery
Have lower rates of infectious disease transmission associated with injection use
There’s a specific clinical advantage for hydrocodone patients worth naming. Because hydrocodone is shorter-acting and more predictable than fentanyl, buprenorphine induction is often smoother for pill-first patients. The COWS window is tighter and more reliable, the transition to steady-state buprenorphine is typically faster, and the subjective experience of starting treatment is usually described as relief within hours rather than the rougher, longer induction sometimes required after long fentanyl exposure. For patients who’ve been quietly dreading this step for months or years, that’s often the most surprising part of the first day on medication. And MAT is not a replacement of one drug with another: buprenorphine’s partial-agonist pharmacology gives it a ceiling on euphoria and respiratory depression that full agonists like hydrocodone, oxycodone, and fentanyl don’t have, so blood levels stabilize, the daily peak-and-crash cycle disappears, and patients can engage in counseling, rebuild relationships, and return to work.
Evidence base: Sordo et al., 2017 (BMJ) mortality meta-analysis; SAMHSA, NIDA, ASAM, and WHO treatment guidelines for opioid use disorder; COMBINE and POATS prescription-opioid buprenorphine trials; and 20+ years of buprenorphine cohort and trial data.
Why Restoration Recovery
Chattanooga’s longest-running outpatient addiction treatment clinic. Decades of clinical experience treating opioid and substance use disorders in Southeast Tennessee — through the full arc of the prescription-opioid era, the heroin transition, and now the fentanyl contamination of the pill supply. We’ve seen every version of this.
CARF accredited. The Commission on Accreditation of Rehabilitation Facilities is the gold standard for outpatient addiction care — reviewed on an ongoing basis, not a one-time stamp.
One integrated team. Medical providers, counselors, certified peer support specialists, and psychiatric care under one roof — not parallel referral tracks that leave you coordinating your own care. For patients with co-occurring chronic pain, anxiety, depression, or hepatitis C, this matters.
Four clinic locations across Southeast Tennessee and North Georgia, with telehealth follow-up available for established patients.
Most major insurance accepted — TennCare, Georgia Medicaid, commercial plans, Medicare, and supplemental Medicare. We verify your benefits before your first visit.
Same-day Suboxone appointments. You don’t have to wait weeks to start.
Licensed in both states. Tennessee and Georgia, HIPAA compliant, 42 CFR Part 2 compliant — your treatment is confidential from the first phone call.
CARF-accredited outpatient addiction care
TennCare, BlueCare, BCBS, UHC, Medicare & most commercial insurance accepted. We verify your benefits before your first visit — no surprises. Licensed in TN & GA · HIPAA · 42 CFR Part 2.
Don’t have insurance? Contact us anyway. We can help you explore options, including TennCare eligibility screening for those who may qualify, and we’ll walk you through self-pay pricing. For a full list of accepted carriers and the verification process, visit our insurance page.
Four Clinic Locations
We operate four outpatient clinics across Southeast Tennessee and North Georgia. All locations offer hydrocodone addiction treatment with same-day appointments available.
Telehealth follow-up visits are available for established patients who have completed their initial in-person evaluation. Phones are answered Monday through Friday, 9am to 4:30pm Eastern. After hours? The 988 Suicide & Crisis Lifeline and the free, confidential SAMHSA National Helpline (1-800-662-4357) are available 24/7.
Questions
Frequently Asked Questions
What if I’ve only been taking pills, not using fentanyl or heroin?+
Prescription-pill patients are a large share of our opioid caseload. Hydrocodone use disorder doesn’t have to progress to fentanyl or heroin to justify treatment — if you’re dependent on pills, you qualify. Many of our patients have never touched an illicit opioid in their lives, and the clinical approach is the same evidence-based MAT with Suboxone, Sublocade, or Brixadi. Induction is often smoother for pill-first patients than for long-term fentanyl patients, because hydrocodone is shorter-acting and its clearance is more predictable.
Is hydrocodone withdrawal less severe than fentanyl withdrawal?+
On balance, yes. Hydrocodone is shorter-acting (onset of withdrawal 6–12 hours after last dose versus 8–24+ hours for fentanyl), the peak phase is often shorter, and the clinical picture is more predictable. The peak discomfort at day 1–3 is still significant — body aches, sweats, nausea, diarrhea, anxiety, insomnia — and it’s more than enough to make an unmedicated quit attempt fail. MAT with buprenorphine prevents that phase rather than forcing you through it, and starting Suboxone same-day is often possible once your COWS score is in the right range.
Can I take Suboxone if I’ve only been using pills for a short time?+
Yes, if a DSM-5 assessment confirms opioid use disorder. Duration of use isn’t the clinical threshold — meeting 2 or more of the 11 DSM-5 criteria in a 12-month period is. Physical dependence can develop in a matter of weeks of daily use, and plenty of hydrocodone patients come in after only a few months of escalating use and meet criteria. A short history doesn’t disqualify you from MAT, and catching dependence early almost always means a shorter, smoother recovery path than catching it years later.
I have chronic pain — will MAT make my pain worse?+
Usually the opposite. Buprenorphine is itself a potent analgesic — it partially activates the same opioid receptors as hydrocodone but without the euphoria, the same overdose risk, or the daily peak-and-crash cycle. Many chronic-pain patients find their pain is better controlled on buprenorphine than it was on escalating hydrocodone doses, because their nervous system is no longer cycling through mini-withdrawal between doses. When appropriate, we coordinate with your pain provider so there’s one consistent plan rather than two contradicting medication lists.
What about counterfeit M30 pills — how do I know if the pills I’ve been using have fentanyl?+
Assume they do. Counterfeit M30 pills — pressed to look like oxycodone 30mg tablets, and in some cases like hydrocodone products — are the dominant illicit pill supply nationally. In 2023, U.S. law enforcement seized roughly 115 million counterfeit pills, accounting for about half of all fentanyl seizures that year. Approximately 6 in 10 seized counterfeit pills in 2022 contained a potentially lethal dose (at least 2 mg of fentanyl). If you’ve been buying pills outside of a pharmacy — any pills, from anyone — fentanyl exposure should be assumed. This doesn’t change the treatment path, but it changes the urgency: the sooner you start MAT, the sooner that exposure stops.
Do I have to stop pills cold turkey before my first visit?+
No. You shouldn’t stop cold turkey on your own, and you don’t need to be in full-blown withdrawal when you call. The COWS assessment at your first visit measures your current withdrawal state and tells the provider whether you’re ready to start buprenorphine that day. For hydrocodone specifically, the target induction window is typically 6–24 hours after your last dose — your provider will guide the exact timing at intake. Starting too early risks precipitated withdrawal; your provider’s job is to make sure that doesn’t happen.
4 clinics across Tennessee & North Georgia
Ready to start hydrocodone addiction treatment?
Same-day appointments available, and most major insurance is accepted. Hydrocodone addiction is treatable — whether your use started with a Vicodin prescription after surgery, a Lortab script for back pain that never quite went away, or somewhere messier than that. You don’t need all the answers before you call, and you don’t need to be clean before your first appointment. Our team will walk you through every step, from your first call to your first visit and every follow-up after.
